V-1, a Protein Expressed Transiently during Murine Cerebellar Development, Regulates Actin Polymerization via Interaction with Capping Protein*

Masato TaokaDagger §, Tohru IchimuraDagger , Akiko Wakamiya-Tsuruta, Yoshiaki KubotaDagger , Takeshi ArakiDagger , Takashi Obinata||, and Toshiaki IsobeDagger **

From the Dagger  Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Hachioji-shi, Tokyo 192-0397, Japan,  Integrated Proteomics System Project, Pioneer Research on Genome the Frontier, Ministry of Education, Culture, Sports, Science and Technology, Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Hachioji-shi, Tokyo 192-0397, Japan, || Department of Biology, Faculty of Science, Chiba University, Chiba 263-8522, Japan, and ** Division of Proteomics Research (ABJ-Millipore), The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan

Received for publication, November 12, 2002, and in revised form, December 9, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

V-1 is a 12-kDa protein consisting of three consecutive ANK repeats, which are believed to serve as the surface for protein-protein interactions. It is thought to have a role in neural development for its temporal profile of expression during murine cerebellar development, but its precise role remains unknown. Here we applied the proteomic approach to search for protein targets that interact with V-1. The V-1 cDNA attached with a tandem affinity purification tag was expressed in the cultured 293T cells, and the protein complex formed within the cells were captured and characterized by mass spectrometry. We detected two polypeptides specifically associated with V-1, which were identified as the alpha  and beta  subunits of the capping protein (CP, alternatively called CapZ or beta -actinin). CP regulates actin polymerization by capping the barbed end of the actin filament. The V-1·CP complex was detected not only in cultured cells transfected with the V-1 cDNA but also endogenously in cells as well as in murine cerebellar extracts. An analysis of the V-1/CP interaction by surface plasmon resonance spectroscopy showed that V-1 formed a stable complex with the CP heterodimer with a dissociation constant of 1.2 × 10-7 M and a molecular stoichiometry of ~1:1. In addition, V-1 inhibited the CP-regulated actin polymerization in vitro in a dose-dependent manner. Thus, our results suggest that V-1 is a novel component that regulates the dynamics of actin polymerization by interacting with CP and thereby participates in a variety of cellular processes such as actin-driven cell movements and motility during neuronal development.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The V-1 protein was originally identified in the murine cerebellum as one of the proteins expressed significantly at the initial stage of postnatal development (1), particularly in the regions where synaptic formation and neuronal migration occur actively during neurogenesis (2, 3). V-1 consists of 117 amino acids containing three contiguous repeats of the ANK motif, alternatively called the cdc10/SWI6 motif (1, 2), which is crucial for a large number of protein-protein interactions (4). Previous studies suggested the potential role of V-1 in the signal transduction pathways leading to catecholamine synthesis or to cardiac hypertrophy. For example, Yamakuni et al. (5-7) demonstrate that the overexpression of V-1 caused a significant increase in the catecholamine level in PC12 cells, presumably through the transcriptional activation of the genes for catecholamine synthesis. In other reports (8-11), V-1 was designated as "myotrophin" and was shown to participate in the cell signaling pathways for the NFkB-mediated activation of protein synthesis in the myocytes. Thus, both of these studies (5, 9) suggested the roles of V-1 in the biological events taking place in the nucleus. However, no biological function has been attributed to V-1 in the cytoplasm in which this molecule predominantly resides within the cells and tissues (5, 9).

In this study, we screened for V-1-binding proteins by a novel proteomic approach that combined the tandem affinity purification (TAP)1 procedure (12) and mass spectrometry (MS). Following this strategy, we identified capping protein (CP) as a V-1-binding protein. We confirmed the existence of the V-1·CP complex not only in cultured cells transfected with the TAP-tagged V-1 but also endogenously in cells and rat cerebellar extracts. Furthermore, we found that V-1 inhibited the CP-regulated actin polymerization. On the basis of these results, the possible role of V-1 in neuronal development is discussed.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Actin monomer was prepared from the acetone-dried powder of rabbit skeletal muscle according to the procedure of Spudich and Watt (13). Pyrene-labeled actin was purchased from Cytoskeleton Inc. (Denver, CO). The polyclonal antibody against the V-1 protein was raised in rabbits injected with the recombinant V-1 protein. The antibody was purified by ammonium sulfate fractionation (0-50% saturation) followed by affinity chromatography on Sepharose beads coupled with the recombinant V-1 protein. The anti-CP monoclonal antibody (14) was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the National Institute of Child Health and Human Development, and maintained by The University of Iowa, Department of Biological Sciences. Oligonucleotides were purchased from Sigma.

Plasmid Constructions-- To construct the cDNA for TAP-tagged V-1, the TAP cDNA (pBS1479) (12) was first digested with BamHI and HindIII and was inserted into the BamHI and EcoRI sites of the mammalian expression vector pcDNA3 (Invitrogen) after blunting the HindIII and EcoRI sites (termed pcDNA3-TAP). The V-1 cDNA was then generated by PCR using the oligonucleotides 5'-GCGAAGCTTATGTGCGACAAGGAGTTCAT-3' and 5'-CTGGATCCCTGGAGAAGAGCTTTGATTG-3' and the rat V-1 cDNA (2). The PCR fragment was digested with HindIII and BamHI and was inserted into the cloning site of pcDNA3-TAP.

The cDNA for GST-tagged V-1 was constructed by PCR amplification of the V-1 cDNA using the oligonucleotides 5'-TAGGATCCTGTGCGACAAGGAGTTCATG-3' and 5'-GCGAATTCTCACTGGAGAAGAGCTTTGA-3' and the rat V-1 cDNA. The PCR fragment was digested with BamHI and EcoRI and was inserted into the cloning sites of the bacterial expression vector pGEX-3X (Amersham Biosciences). The V-1 cDNA was also amplified by PCR using the oligonucleotides 5'-TACCATGGGATGTGATAAAGAGTTCATG-3' and 5'-GTTCATGGATCCATCACTGGAGAAGAGC-3' and the rat V-1 cDNA. The resulting fragment was digested with NdeI and BamHI and was inserted into the cloning sites of the bacterial expression vector, pET 15b (Novagen, Madison, WI).

Cell Culture and Immunoprecipitation-- Human embryonic kidney 293 T cells (293T) were maintained in Dulbecco's modified Eagle's medium containing 10% fetal calf serum (Invitrogen) as described previously (15). The cells (2 × 106 cells) were cultured in a 100-mm dish and were transfected the following day with 8 µg of cDNA using the Polyfect transfection reagent (Qiagen, Hilden, Germany) according to the manufacturer's instructions. After 48 h, the cells were washed twice with phosphate-buffered saline and were immediately scraped into 500 µl of lysis buffer containing 50 mM Tris-HCl (pH 8.0), 10% glycerol, 1% Triton X-100, 150 mM NaCl, 100 mM NaF, 5 µM ZnCl2, 1 mM Na3VO4, 10 mM EGTA, 2 µg/ml leupeptin, and 4 mM phenylmethylsulfonyl fluoride. The cell lysate was centrifuged at 100,000 × g for 20 min at 4 °C, and the supernatant (~5-mg protein) was incubated with 20 µl of IgG-Sepharose beads (Amersham Biosciences) for 2 h at 4 °C. The IgG beads were washed five times with 500 µl of a buffer containing 20 mM Tris-HCl (pH 7.5), 5% glycerol, 0.1% Triton X-100, and 150 mM NaCl and twice with 50 mM Tris-HCl (pH 8.0). The beads were then mixed with tobacco etch virus protease (Invitrogen) at room temperature for 1 h in 50 mM Tris-HCl (pH8.0) to release the protein complex into solution. The complex was subsequently incubated with 20 µl of calmodulin-agarose beads (Stratagene, La Jolla, CA) in a buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 1 mM CaCl2. After washing the beads twice with the same buffer, the bound proteins were eluted from the beads with this buffer containing 4 mM EDTA instead of 1 mM CaCl2.

In-gel Digestion and Tandem Mass Spectrometry-- Protein bands (0.2 × 0.8 cm) were excised from the SDS gel, dehydrated with acetonitrile, and vacuum-dried. The gel pieces were swollen in 10 µl of 100 mM Tris-HCl (pH 8.8), and the proteins were in-gel digested overnight with 250 ng of trypsin (Promega, Madison, WI) at 37 °C. The peptide fragments were extracted from the gel with 100 µl of 50% acetonitrile in 5% formic acid and were concentrated by adsorption onto 0.1 µl of reversed-phase beads (POROS R2, Applied Biosystems, Foster, CA). After the beads were washed twice with 400 µl of 0.1% trifluoroacetic acid, the bound peptides were recovered with 2 µl of 50% methanol in 5% acetic acid. The peptide mixture was then analyzed by tandem mass spectrometry on a electrospray ionization quadrupole time-of-flight mass spectrometer (Q-TOF2, Micromass, Manchester, United Kingdom) equipped with a nanospray tip. All of the MS/MS spectra were searched against the non-redundant protein sequence data base maintained at the National Center for Biotechnology Information to identify proteins by the Mascot program (Matrixscience, London, United Kingdom). The MS/MS signal assignments were confirmed manually.

Expression and Purification of Recombinant Proteins-- Recombinant V-1 protein was expressed in Escherichia coli (BL21) and was purified by ammonium sulfate fractionation (50-85% saturation) followed by anion exchange chromatography on a DEAE-5PW column (0.75 × 15 cm, TOSOH, Tokyo, Japan). The GST-tagged V-1 protein (GST-V-1) was purified with glutathione-Sepharose beads (Amersham Biosciences) as described previously (16). The CP heterodimer consisting of alpha  and beta  subunits was produced in E. coli (BL21) using the simultaneous expression system as described by Soeno et al. (17). For the experiment shown in Fig. 3, A and B, the alpha  and beta  subunits were each expressed separately in E. coli (BL21). Because the expressed alpha  and beta  subunits were each recovered in the insoluble fraction, the precipitates were collected and dissolved in buffer A (2 mM dithiothreitol, 50 mM Tris-HCl (pH 7.5)) containing 8 M urea. The concentration of urea was then decreased to 0.06 M by a two-step dilution. First, the solution was diluted with buffer A containing 6 M urea to a protein concentration of 200 nmol protein/ml, and the insoluble material was removed by centrifugation. The soluble fraction then was diluted 100-fold with the surface plasmon resonance (SPR) buffer (150 mM NaCl, 3 mM EDTA, 0.005% Polysorbate 20, 10 mM HEPES (pH 7.4)). For the experiment shown in Fig. 3B, the alpha  and beta  subunits were mixed and reconstituted to the heterodimer at 4 °C for 10 min.

Surface Plasmon Resonance Analysis-- All of the studies were performed on a Biacore 2000 instrument (Biacore, Uppsala, Sweden). The GST or GST-fused V-1 protein was immobilized on the CM5 sensor chip via an anti-GST antibody (Biacore). The concentration of the immobilized protein was adjusted to yield ~180 resonance units. The V-1/CP interaction analysis was carried out at 25 °C by introducing CPalpha , CPbeta , or the reconstituted CP heterodimer (1 µM) at a flow rate of 20 µl/min into the Biacore instrument, and the changes in the SPR signals were recorded. For the kinetic analysis, various concentrations of the CP heterodimer were loaded on the sensor surface to equilibrate the V-1/CP interaction, and the concentration of the complex (Req) was measured as the response units. The correlation among Req, the concentration of ligand (C) passed over the sensor surface, and the total binding capacity (Rmax) of the immobilized protein was: Req/C = KaRmax - KaReq (18). Thus, the association constant (Ka) was determined from the plot of Req/C versus Req estimated at different CP concentrations by a Scatchard plot analysis.

Assay of CP-mediated Actin Nucleation and Depolymerization-- The CP-mediated actin nucleation and depolymerization were analyzed essentially according to the procedures described by Higashi and Oosawa (19) and Schafer et al. (14), respectively. For the actin nucleation assay, 4.8 µM actin monomer and 0.48 µM CP were incubated in a G-actin buffer (0.1 mM CaCl2, 0.2 mM ATP, 2 mM HEPES-KOH (pH7.0)) in the presence or absence of 2.4 µM V-1 for 10 min at room temperature, and the polymerization was initiated in 50 mM KCl, 1 mM MgCl2, and 10 mM HEPES-KOH (pH 7.0). The actin nucleation was assayed as the initial rate of increase in the absorbance at 237 nm. For the actin depolymerization assay, the F-actin was prepared by polymerizing 4.8 µM actin (50% Pyrene-labeled) for 90 min at 25 °C in F-actin buffer (2 mM MgCl2, 100 mM KCl, 0.1 mM CaCl2, 0.2 mM ATP, 10 mM HEPES-KOH (pH7.0)). The depolymerization was initiated by the dilution of 25 µl of F-actin solution with 1.2 ml of G-actin buffer containing 10 µg/ml human serum albumin, 10 nM CP, and various amounts of recombinant V-1. The depolymerization of actin filaments was assayed by monitoring the changes in fluorescence at 407 nm of the Pyrene-labeled actin with an excitation wavelength at 365 nm.

F-actin Co-sedimentation Assay and Other Analytical Methods-- Actin monomer (4.8 µM) was polymerized for 90 min at 25 °C in the F-actin buffer in the presence of CP (3 µM) with or without 15 µM V-1 protein. The polymerized mixture was centrifuged for 30 min at 100,000 × g, and the precipitates were analyzed by SDS-PAGE (CBB staining). SDS-PAGE and Western blotting were carried out as described previously (20). Silver staining was performed without glutaraldehyde (21).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of CP as a V-1-binding Protein-- To search for the V-1-binding protein, we carried out an affinity purification experiment using the TAP method (12). The TAP method utilizes two affinity modules (a calmodulin-binding peptide and a protein A epitope) separated by a cleavage site for the tobacco etch virus protease. Therefore, the purification produces much less background than the conventional single epitope tags such as Myc or hemagglutinin. To adapt this method for our purpose, we constructed a mammalian expression vector encoding V-1 with a carboxyl-terminal TAP tag, transiently transformed 293T cells with the vector, and purified the tagged V-1 with its binding proteins from the cell lysate by the TAP method. Fig. 1A, lane 2, shows the SDS-PAGE photographs of the purified protein complex. In addition to the tagged V-1 used as bait, the 36- and 33-kDa polypeptide bands were reproducibly detected in the cells transfected with a TAP-tagged V-1 but not in the control cells (Fig. 1A, lane 1), suggesting that these polypeptides were associated with the expressed V-1 protein. These bands (assigned as bands 1 and 2 in Fig. 1A) were excised from the gel and subjected to in-gel tryptic digestion, and the peptide fragments thus generated were analyzed by nanoelectrospray tandem mass spectrometry, respectively.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   Identification of CP as a V-1-binding protein. A, the 293T cells were transfected with the TAP-tagged V-1 construct (lane 2) or the vector alone (lane 1), and the expressed protein was recovered with the associating proteins as described under "Experimental Procedures." The proteins were analyzed by SDS-PAGE (10% polyacrylamide gel, silver staining). The molecular mass markers are shown on the left, and the positions of CPalpha (36 kDa) and beta  (33 kDa) are indicated by arrows. The asterisk indicates the TAP-tagged V-1 protein. B and C, the doubly charged ions of the tryptic peptide (m/z = 599.40) from the 36-kDa band (B) and of the tryptic peptide (m/z = 586.30) from the 33-kDa band (C) were analyzed by nanoelectrospray ionization-MS/MS. The amino acid sequences were verified by manual interpretation of the b-type (italic text) and y-type (normal text) product ion series as indicated in the figure.

Two doubly charged peptide ions with m/z 599.40 and 786.00, were observed from band 1. The data base analysis of the MS/MS spectrum of the peptide ion with m/z 599.40 showed that it corresponded to the sequence LLLNNDNLLR of CPalpha (GenBankTM accession number P52907) at residues 38-47. The manual assignment of the fragment ions also yielded the same sequence (Fig. 1B). Likewise, the MS/MS spectrum of the other peptide ion with m/z 786.00 was assigned to the sequence FTITPPTAQVVGVLK of CPalpha at residues 179-193 (data not shown), confirming that band 1 contained CPalpha . From band 2, two doubly charged peptide ions with m/z 586.20 and 677.30 were observed. The analysis of their collision-induced dissociation fragments indicated that one (m/z 586.20) corresponded to the sequence STLNEIYFGK of CPbeta (GenBankTM accession number P47756) at residues 226-235 (Fig. 1C) and the other (m/z 677.30) corresponded to the sequence SGSGTMNLGGSLTR of the same polypeptide at residues 182-195 (data not shown). The molecular weights of bands 1 and 2 estimated by SDS-PAGE (Fig. 1A) were also agreed with those of the respective CP subunits (32,902 and 31,331). Because CP is a stable heterodimer of alpha  and beta  subunits (22, 23) and because these polypeptides appear in almost equimolar amounts in the captured V-1 complex (Fig. 1A), we anticipated that V-1 bound the CP heterodimer itself.

Detection of the Endogenous V-1·CP Complex-- The overexpression of a particular protein sometimes induces artificial interactions among proteins, which do not occur under physiological conditions. To exclude the possibility that the observed interaction between V-1 and CP might be artificial, we sought to detect the endogenous V-1·CP complex in cultured 293T cells as well as in rat cerebella. Soluble extracts were prepared from 293T cells or from rat cerebella at a postnatal day 12, and the V-1 protein was immunoprecipitated from the extracts with the anti-V-1 IgG immobilized on Sepharose beads. The precipitate was then analyzed by SDS-PAGE followed by immunoblotting with the antibody against the CPbeta subunit. As shown in Fig. 2, the CPbeta was clearly detected in the precipitates derived both from the 293T cells and the rat cerebella, suggesting that the V-1·CP complex was present under physiological conditions in vivo.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 2.   Detection of the endogenous V-1·CP complex. The lysate of 293T cells or the extract of rat cerebella on postnatal day 14 (~5 mg of protein) was incubated with the anti-V-1 (V-1) or preimmune (ctrl) antibody. The resulting immunoprecipitates (IP) were collected on protein A-Sepharose beads, subjected to SDS-PAGE, and analyzed by immunoblotting (IB) with the anti-CPbeta antibody (upper panel) or with the anti-V-1 antibody (lower panel).

Biochemical Properties of the Interaction between V-1 and CP-- To study the biochemical characteristics of the V-1·CP complex in further detail, we prepared a number of materials including V-1, GST-tagged V-1, and the CPalpha and beta  subunits. These proteins were expressed in the E. coli cells and were purified to near homogeneity as observed by SDS-PAGE (Fig. 3A). First, we studied the complex formation of V-1 and CP by SPR. For the direct binding assay on the SPR biosensor, the GST-V-1 protein was attached to the sensor surface via the GST antibody, and the recombinant CP was passed over the sensor chip. As shown in Fig. 3B, positive binding signals were detected when the CP heterodimer, reconstituted from the recombinant CPalpha and beta  subunits, was introduced to the sensor chip. Interestingly, however, the purified CPalpha or CPbeta alone gave no SPR signals (Fig. 3B) even with repeated binding experiments using different subunit preparations, suggesting that V-1 bound specifically to the heterodimeric CP molecule. To obtain kinetic data of the complex formation, the steady-state resonance was measured using various concentrations of CP (Fig. 3C). The results showed that the immobilized V-1 was saturable with respect to the CP binding and the association constant calculated from the slope of the straight line of the corresponding Scatchard plot (inset) was 8.4 × 106 M. The Ka value was not influenced by the amount of immobilized V-1 protein (data not shown). The equilibrium dissociation constant (Kd) calculated from 1/Ka was 1.2 × 10-7 M, indicating that the V-1·CP complex is relatively stable.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Biochemical characterization of the V-1·CP complex. A, SDS-PAGE profiles of the CPalpha (lane 1), CPbeta (lane 2), GST-V-1 (lane 3), and V-1 (lane 4) protein used for the binding experiments (CBB staining). The molecular mass markers are indicated on the left. B, analysis of the interaction of CP and V-1 on the SPR Biosensor (Biacore 2000). The running buffer was 10 mM HEPES (pH7.4) containing 150 mM NaCl, 3 mM EDTA, and 0.005% Polysorbate 20. The GST-fused V-1 protein was immobilized on a sensor chip, and the SPR signals were measured to monitor the binding to CPalpha (alpha ), CPbeta (beta ), and the CP heterodimer (alpha beta ). The resonance unit (RU), a relative indicator of the protein-protein interaction, is plotted as a function of time in seconds. C, steady-state resonance (Req) is plotted at each CP concentration. Inset, the Scatchard plot derived from the data in C for CP. The straight line was drawn by the method of least squares. D, native-PAGE assay. Left panel, V-1 or CP alone (lanes 1 and 2) or the mixture of V-1 and CP (lane 3) was analyzed by PAGE on a 4% gel without SDS in 25 mM Tris and 194 mM glycine (pH 9.0). The concentration of V-1 was 2 µM (lane 1) or 20 µM (lane 3), respectively, and the concentration of CP was 2 µM (lanes 2 and 3). Electrophoresis was performed at 20 mA for 50 min, and the gel was stained with CBB. Right panel, the stained bands indicated as CP (lane 2) and Complex (lane 3) were excised from the gel, destained in 20% MeOH containing 7% AcOH, and then analyzed by SDS-PAGE (CP, lane 4; complex, lane 5) (CBB staining). The proteins were semi-quantitated by densitometry performed as described previously (21).

To clarify the formation of the V-1·CP complex and to determine the molecular stoichiometry, the "native-PAGE assay" (24) was performed (Fig. 3D). When the recombinant V-1 was mixed with CP under physiological conditions and was analyzed by gel electrophoresis without chaotropic reagents, a new protein band appeared that migrated between the V-1 and CP heterodimer (Fig. 3D, left panel). The subsequent analysis of this protein band by SDS-PAGE revealed that it was a V-1·CP complex, because it contained V-1 and the CPalpha and beta  subunits (Fig. 3D, right panel). The semi-quantitative analysis of the CBB-stained bands indicated that the density of each polypeptide band was 1.0:0.8:1.0 for CPalpha , beta , and V-1, respectively. This finding suggests that the binding stoichiometry of the V-1·CP-heterodimer complex is ~1:1, i.e. one V-1 molecule associates with one CP heterodimer. V-1 exists in the mouse cerebellum at a concentration of 3.7 × 10-7 M as estimated by quantitative immunoblotting,2 and this concentration is almost the same level as that of CP (2 congruent  20 × 10-7 M) reported in previous studies (14, 32, 33). Thus, the V-1/CP interaction could occur under physiological condition in terms of cellular levels of V-1 and CP and the binding kinetics of these proteins.

Suppression of CP Activity by V-1-- CP nucleates actin polymerization and caps the barbed ends of actin filaments (14, 23, 25, 26). To examine the effects of V-1 protein on the activities of CP, we assayed the initial rates of polymerization with the CP-nucleated actin and depolymerization of the CP-capped F-actin in the presence and absence of the V-1 protein. For the CP-nucleated actin polymerization, we monitored the changes in optical absorption to measure the initial rate of actin polymerization. As shown in Fig. 4Aa, CP markedly increased the initial rate of actin polymerization and the V-1 protein canceled this CP function. The difference in the initial rate of polymerization between CP-nucleated actin in the presence and absence of the V-1 protein was statistically significant (Fig. 4Ab). The V-1 protein reduced the nucleation activity of CP in a dose-dependent manner, whereas V-1 alone had no effect on the actin polymerization (data not shown). Besides this activity, we also measured the effects of V-1 on the dilution-induced depolymerization of the CP-capped actin filaments by monitoring the changes in fluorescence (Fig. 4B). After the preincubation with V-1, CP reduced its capping activity to depolymerize the actin filaments. Thus, the capping activity of CP was dependent on the concentration of V-1, whereas V-1 alone had no effect on the actin depolymerization. These results demonstrate that the V-1 protein suppressed the CP activities of both actin nucleation and F-actin capping.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Inhibition of CP-mediated actin nucleation and capping by the V-1 protein. A, effect of V-1 on the CP-mediated actin nucleation. Actin and the indicated proteins were incubated for 10 min at room temperature, and the actin polymerization was initiated by adding the salt solution (50 mM KCl and 1 mM MgCl2) into the mixture. The actin nucleation was monitored by UV absorption at 237 nm. The time-course representation (a) and the statistical evaluation (b) of the V-1 activity on CP-nucleated actin polymerization are shown. The rate of actin nucleation in b was measured as the rate of increase in absorbance for the first 100 s. Each value represents the ratio to the control experiment (b, No addition) and the mean ± S.E. of three independent measurements. Asterisks indicate significant difference by Student's t test (p < 0.005) from CP (*) and CP+V-1 (**). B, effect of V-1 on the capping activity of CP in the F-actin depolymerization. The F-actin was prepared as described under "Experimental Procedures," and the depolymerization was initiated by dilution with the buffer containing CP and V-1 at the molar ratios indicated in the figure. The fluorescence changes in the pyrene-labeled actin versus time after dilution are shown.

Interaction between the V-1·CP Complex and F-actin-- We studied whether the V-1·CP complex bound F-actin by using a co-sedimentation assay. The actin monomer was polymerized and co-sedimented with CP in the presence or absence of the V-1 protein, and aliquots of the precipitates were analyzed by SDS gel electrophoresis. As shown in Fig. 5, CP co-sedimented with F-actin only in the absence of the V-1 protein. Thus, V-1 appeared to form a stable complex with CP and to prevent CP binding to F-actin.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   V-1 induced inhibition of the CP/F-actin interaction. The actin monomer was polymerized in the presence of CP with (lane 1) or without the V-1 protein (lane 2). After centrifugation, the precipitate (2.5-µg protein) was analyzed by SDS-PAGE to detect the CP that co-sedimented with the actin filament (CBB staining).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

CP is one of the F-actin-binding proteins that caps the barbed end of actin filaments and nucleates the actin polymerization in a Ca2+-independent (22, 23, 27, 28) and a phosphatidylinositol 4,5-bisphosphate-dependent manner (29-32). This activity is thought to be functionally significant, because the actin-based movement of Dictyostelium is proportional to the expression level of CP (33) and because CP is essential for the in vitro reconstitution of the cell movement (34, 35). In this study, we have shown that the V-1 protein forms a stable stoichiometric complex with CP in vitro as well as in vivo (Figs. 2 and 3) and inhibits the CP-mediated nucleation of actin polymerization. Therefore, we assume that V-1 participates in the regulation of actin dynamics in the cells via the interaction with CP.

Our strategy to identify the V-1-interacting molecules was based on the tandem affinity purification of the V-1 complex with a TAP tag followed by protein identification by mass spectrometry. The TAP method was originally developed to analyze interactions among yeast proteins (12). We constructed a mammalian expression vector for the TAP method and applied it to the mammalian 293T cell line. Even though the V-1 protein is a rather minor cellular component and a transient expression system was used for the assay, the method enabled us to isolate a sufficient amount of the V-1·CP complex for characterization by nanospray tandem mass spectrometry (Fig. 1). This affinity-tag technique coupled with mass spectrometry is useful to detect novel protein interactions not only in yeast but also in mammalian cells.

The V-1 protein consists of three consecutive ANK repeats with an additional short stretch of sequence (1, 2, 37). The ANK repeat is a structural motif found in many proteins (36) and mediates specific interactions with a diverse array of protein targets (4). In the tertiary structure of V-1 determined by NMR spectroscopy (37), the ANK repeats comprise the hairpin-helix-loop-helix modules where the alpha  helices lie along one side providing a structural framework and the hairpins protrude on the other side of the molecule. The hairpins and the surface of the alpha  helices form a groove-like structure, which is believed to be responsible for the contact with the target molecule. This study identified CP as a potential target of V-1. Interestingly, V-1 bound to the functional CP heterodimer consisting of the alpha  and beta  subunits but did not bind each of the two subunits. This finding is comparable with previous observations that each of the CP subunits was unstable and did not bind actin in vitro and in vivo (26, 38, 39). Thus, it seems likely that V-1 recognizes the structural interface of the CP heterodimer by its groove-like ANK repeats and covers the F-actin binding surface located in the carboxyl-terminal region of the CPbeta subunit (26). However, whether this is the molecular mechanism by which V-1 inhibits the interaction of CP and F-actin awaits further structural investigation.

Two distinct proteins, carmil (40) and twinfilin (24), are known to bind CP. Carmil is a scaffold protein containing the CP-binding site, the myosin I-binding site, the short sequence commonly found in several actin monomer-binding proteins, and the acidic stretch that can activate Arp2/3-dependent actin nucleation (40). The NH2-terminal region of carmil binds CP, but its activity with CP is unknown. Twinfilin is a ubiquitous actin monomer-binding protein composed of two ADF/cofilin-like domains connected by a short linker region and has a role in the regulation of actin turnover (41). Twinfilin also forms a stable complex with CP but does not affect its activity. V-1 is neither a scaffold protein nor an actin-binding protein, and it lacks structural homology to either carmil or twinfilin. Thus, V-1 belongs to a novel CP-binding protein category. Recently, Ena/VASP was reported as an anti-capping molecule, which promotes actin filament elongation by associating with the barbed ends of actin and shielding them from CP (42). The actin cytoskeleton in the Ena/VASP-deficient cell contained shorter, more highly branched filaments than those in the control cells. V-1 resembles Ena/VASP in the activity of CP-regulated actin polymerization, but whether a similar phenotype can be attributed to the V-1-deficient cell is currently unknown.

Previous studies suggested the potential roles of V-1 in nuclear events such as the transcriptional activation of a set of enzymes involved in catecholamine synthesis (5-7) or the regulation of de novo protein synthesis (8-10, 43). This study suggests for the first time that V-1 functions in the molecular events taking place in the cytoplasm in which the major portion of V-1 resides within the cells as revealed by previous immunohistochemical studies (5, 9). V-1 also appeared to be a typical cytoplasmic protein in terms of amino acid sequence with no apparent nuclear localization signal. Our previous studies revealed the characteristic temporal profile of V-1 expression in the developing murine cerebellum at postnatal days 7-12 (2). Namely, V-1 expression is particularly significant during the migration of progenitor granule cells from the external to internal granular layer to make synaptic contacts with the target Purkinje cells. Likewise, the dynamics of actin polymerization play a pivotal role in the maturation of granule cells, because the modulation of the barbed ends of actin filaments with cytochalasins changed the behavior of the growth cone (44) and the migration of granule cells (45). These observations coupled with the results reported here suggest that V-1 may have a role in the CP-mediated actin-driven cell movements and motility such as granular cell migration and synapse formation.

    FOOTNOTES

* This study was supported in part by grants for the Integrated Proteomics System Project and Pioneer Research on Genome the Frontier from the Ministry of Education, Culture, Sports, Science and Technology of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minami-Osawa 1-1, Hachioji, Tokyo 192-0397, Japan. Fax: 81-426-77-2525; E-mail: mango@comp.metro-u.ac.jp.

Published, JBC Papers in Press, December 16, 2002, DOI 10.1074/jbc.M211509200

2 M. Taoka, unpublished result.

    ABBREVIATIONS

The abbreviations used are: TAP, tandem affinity purification; CP, capping protein; GST, glutathione S-transferase; MS/MS, tandem mass spectrometry; SPR, surface plasmon resonance; CBB, Coomassie Brilliant Blue; 293T, human embryonic kidney 293 T cells.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Taoka, M., Yamakuni, T., Song, S. Y., Yamakawa, Y., Seta, K., Okuyama, T., and Isobe, T. (1992) Eur. J. Biochem. 207, 615-620[Abstract]
2. Taoka, M., Isobe, T., Okuyama, T., Watanabe, M., Kondo, H., Yamakawa, Y., Ozawa, F., Hishinuma, F., Kubota, M., Minegishi, A., Song, S. Y., and Yamakuni, T. (1994) J. Biol. Chem. 269, 9946-9951[Abstract/Free Full Text]
3. Fujigasaki, H., Song, S. Y., Kobayashi, T., and Yamakuni, T. (1996) Mol. Brain Res. 40, 203-213[Medline] [Order article via Infotrieve]
4. Sedgwick, S. G., and Smerdon, S. J. (1999) Trends Biochem. Sci. 24, 311-316[CrossRef][Medline] [Order article via Infotrieve]
5. Yamakuni, T., Yamamoto, T., Hoshino, M., Song, S. Y., Yamamoto, H., Kunikata-Sumitomo, M., Minegishi, A., Kubota, M., Ito, M., and Konishi, S. (1998) J. Biol. Chem. 273, 27051-27054[Abstract/Free Full Text]
6. Suzuki, T., Inagaki, H., Yamakuni, T., Nagatsu, T., and Ichinose, H. (2002) Biochem. Biophys. Res. Commun. 293, 962-968[CrossRef][Medline] [Order article via Infotrieve]
7. Suzuki, T., Yamakuni, T., Hagiwara, M., and Ichinose, H. (2002) J. Biol. Chem. 277, 40768-40774[Abstract/Free Full Text]
8. Gupta, S., and Sen, S. (2002) Biochim. Biophys. Acta 1589, 247-260[Medline] [Order article via Infotrieve]
9. Knuefermann, P., Chen, P., Misra, A., Shi, S. P., Abdellatif, M., and Sivasubramanian, N. (2002) J. Biol. Chem. 277, 23888-23897[Abstract/Free Full Text]
10. Sivasubramanian, N., Adhikary, G., Sil, P. C., and Sen, S. (1996) J. Biol. Chem. 271, 2812-2816[Abstract/Free Full Text]
11. Sil, P., Kandaswamy, V., and Sen, S. (1998) Circ. Res. 82, 1173-1188[Abstract/Free Full Text]
12. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., and Seraphin, B. (1999) Nat. Biotechnol. 17, 1030-1032[CrossRef][Medline] [Order article via Infotrieve]
13. Spudich, J. A., and Watt, S. (1971) J. Biol. Chem. 246, 4866-4871[Abstract/Free Full Text]
14. Schafer, D. A., Jennings, P. B., and Cooper, J. A. (1996) J. Cell Biol. 135, 169-179[Abstract]
15. Fujiyama, S., Yanagida, M., Hayano, T., Miura, Y., Isobe, T., and Takahashi, N. (2002) J. Biol. Chem. 277, 23773-23780[Abstract/Free Full Text]
16. Ichimura, T., Uchiyama, J., Kunihiro, O., Ito, M., Horigome, T., Omata, S., Shinkai, F., Kaji, H., and Isobe, T. (1995) J. Biol. Chem. 270, 28515-28518[Abstract/Free Full Text]
17. Soeno, Y., Abe, H., Kimura, S., Maruyama, K., and Obinata, T. (1998) J. Muscle Res. Cell Motil. 19, 639-646[CrossRef][Medline] [Order article via Infotrieve]
18. Banik, U., Wang, G. A., Wagner, P. D., and Kaufman, S. (1997) J. Biol. Chem. 272, 26219-26225[Abstract/Free Full Text]
19. Higashi, S., and Oosawa, F. (1965) J. Mol. Biol. 12, 843-865[Medline] [Order article via Infotrieve]
20. Itagaki, C., Isobe, T., Taoka, M., Natsume, T., Nomura, N., Horigome, T., Omata, S., Ichinose, H., Nagatsu, T., Greene, L. A., and Ichimura, T. (1999) Biochemistry 38, 15673-15680[CrossRef][Medline] [Order article via Infotrieve]
21. Taoka, M., Wakamiya, A., Nakayama, H., and Isobe, T. (2000) Electrophoresis 21, 1872-1879[CrossRef][Medline] [Order article via Infotrieve]
22. Maruyama, K., Kimura, S., Ishii, T., Kuroda, M., Ohashi, K., and Muramats, S. (1977) J. Biochem. 81, 215-232[Abstract]
23. Caldwell, J. E., Heiss, S. G., Mermall, V., and Cooper, J. A. (1989) Biochemistry 28, 8506-8514[Medline] [Order article via Infotrieve]
24. Palmgren, S., Ojala, P. J., Wear, M. A., Cooper, J. A., and Lappalainen, P. (2001) J. Cell Biol. 155, 251-260[Abstract/Free Full Text]
25. Cooper, J. A., and Pollard, T. D. (1985) Biochemistry 24, 793-799[Medline] [Order article via Infotrieve]
26. Hug, C., Miller, T. M., Torres, M. A., Casella, J. F., and Cooper, J. A. (1992) J. Cell Biol. 116, 923-931[Abstract]
27. Maruyama, K., Kurokawa, H., Oosawa, M., Shimaoka, S., Yamamoto, H., and Ito, M. (1990) J. Biol. Chem. 265, 8712-8715[Abstract/Free Full Text]
28. Casella, J. F., Maack, D. J., and Lin, S. (1986) J. Biol. Chem. 261, 10915-10921[Abstract/Free Full Text]
29. Heiss, S. G., and Cooper, J. A. (1991) Biochemistry 30, 8753-8758[Medline] [Order article via Infotrieve]
30. Haus, U., Hartmann, H., Trommler, P., Noegel, A. A., and Schleicher, M. (1991) Biochem. Biophys. Res. Commun. 181, 833-839[Medline] [Order article via Infotrieve]
31. Barkalow, K., Witke, W., Kwiatkowski, D. J., and Hartwig, J. H. (1996) J. Cell Biol. 134, 389-399[Abstract]
32. DiNubile, M. J., and Huang, S. (1997) Biochim. Biophys. Acta 1358, 261-278[Medline] [Order article via Infotrieve]
33. Hug, C., Jay, P. Y., Reddy, I., McNally, J. G., Bridgman, P. C., Elson, E. L., and Cooper, J. A. (1995) Cell 81, 591-600[Medline] [Order article via Infotrieve]
34. Loisel, T. P., Boujemaa, R., Pantaloni, D., and Carlier, M. F. (1999) Nature 401, 613-616[CrossRef][Medline] [Order article via Infotrieve]
35. Pantaloni, D., Boujemaa, R., Didry, D., Gounon, P., and Carlier, M. F. (2000) Nat. Cell Biol. 2, 385-391[CrossRef][Medline] [Order article via Infotrieve]
36. Rubin, G. M., Yandell, M. D., Wortman, J. R., Gabor Miklos, G. L., Nelson, C. R., Hariharan, I. K., Fortini, M. E., Li, P. W., Apweiler, R., Fleischmann, W., Cherry, J. M., Henikoff, S., Skupski, M. P., Misra, S., Ashburner, M., Birney, E., Boguski, M. S., Brody, T., Brokstein, P., Celniker, S. E., Chervitz, S. A., Coates, D., Cravchik, A., Gabrielian, A., Galle, R. F., Gelbart, W. M., George, R. A., Goldstein, L. S., Gong, F., Guan, P., Harris, N. L., Hay, B. A., Hoskins, R. A., Li, J., Li, Z., Hynes, R. O., Jones, S. J., Kuehl, P. M., Lemaitre, B., Littleton, J. T., Morrison, D. K., Mungall, C., O'Farrell, P. H., Pickeral, O. K., Shue, C., Vosshall, L. B., Zhang, J., Zhao, Q., Zheng, X. H., and Lewis, S. (2000) Science 287, 2204-2215[Abstract/Free Full Text]
37. Yang, Y., Nanduri, S., Sen, S., and Qin, J. (1998) Structure 6, 619-626[Medline] [Order article via Infotrieve]
38. Amatruda, J. F., Gattermeir, D. J., Karpova, T. S., and Cooper, J. A. (1992) J. Cell Biol. 119, 1151-1162[Abstract]
39. Hart, M. C., and Cooper, J. A. (1999) J. Cell Biol. 147, 1287-1298[Abstract/Free Full Text]
40. Jung, G., Remmert, K., Wu, X., Volosky, J. M., and Hammer, J. A., III (2001) J. Cell Biol. 153, 1479-1497[Abstract/Free Full Text]
41. Palmgren, S., Vartiainen, M., and Lappalainen, P. (2002) J. Cell Sci. 115, 881-886[Abstract/Free Full Text]
42. Bear, J. E., Svitkina, T. M., Krause, M., Schafer, D. A., Loureiro, J. J., Strasser, G. A., Maly, I. V., Chaga, O. Y., Cooper, J. A., Borisy, G. G., and Gertler, F. B. (2002) Cell 109, 509-521[Medline] [Order article via Infotrieve]
43. Schroder, H. C., Krasko, A., Batel, R., Skorokhod, A., Pahler, S., Kruse, M., Muller, I. M., and Muller, W. E. (2000) FASEB J. 14, 2022-2031[Abstract/Free Full Text]
44. Zmuda, J. F., and Rivas, R. J. (2000) J. Cell Sci. 113, 2797-2809[Abstract/Free Full Text]
45. Rivas, R. J., and Hatten, M. E. (1995) J. Neurosci. 15, 981-989[Abstract]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.